DK0616613T3 - Fragmenter af prionprotein - Google Patents

Fragmenter af prionprotein

Info

Publication number
DK0616613T3
DK0616613T3 DK92924777T DK92924777T DK0616613T3 DK 0616613 T3 DK0616613 T3 DK 0616613T3 DK 92924777 T DK92924777 T DK 92924777T DK 92924777 T DK92924777 T DK 92924777T DK 0616613 T3 DK0616613 T3 DK 0616613T3
Authority
DK
Denmark
Prior art keywords
protein fragments
prion protein
polypeptides
antibodies
manufacture
Prior art date
Application number
DK92924777T
Other languages
English (en)
Inventor
Robert Vincent Bradl Fishleigh
Barry Robson
Roger Paul Mee
Original Assignee
Proteus Molecular Design
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26299955&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0616613(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB919125747A external-priority patent/GB9125747D0/en
Priority claimed from GB929214663A external-priority patent/GB9214663D0/en
Application filed by Proteus Molecular Design filed Critical Proteus Molecular Design
Application granted granted Critical
Publication of DK0616613T3 publication Critical patent/DK0616613T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK92924777T 1991-12-03 1992-12-03 Fragmenter af prionprotein DK0616613T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919125747A GB9125747D0 (en) 1991-12-03 1991-12-03 Synthetic polypeptides
GB929214663A GB9214663D0 (en) 1992-07-10 1992-07-10 Synthetic polypeptides
PCT/GB1992/002246 WO1993011155A1 (en) 1991-12-03 1992-12-03 Fragments of prion proteins

Publications (1)

Publication Number Publication Date
DK0616613T3 true DK0616613T3 (da) 1999-09-27

Family

ID=26299955

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92924777T DK0616613T3 (da) 1991-12-03 1992-12-03 Fragmenter af prionprotein

Country Status (12)

Country Link
US (3) US5773572A (da)
EP (1) EP0616613B1 (da)
JP (1) JP4233604B2 (da)
AT (1) ATE177754T1 (da)
AU (1) AU675053B2 (da)
CA (1) CA2124953C (da)
DE (1) DE69228701T2 (da)
DK (1) DK0616613T3 (da)
ES (1) ES2128362T3 (da)
GR (1) GR3029740T3 (da)
NZ (1) NZ246059A (da)
WO (1) WO1993011155A1 (da)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618673A (en) * 1991-08-20 1997-04-08 British Technology Group Limited Oligonucleotides and their use in an assay for encephalopathies
CN1091138A (zh) 1992-08-27 1994-08-24 迪金研究有限公司 疫苗
DE4402756A1 (de) * 1994-01-31 1995-08-03 Boehringer Mannheim Gmbh Spezifische Bindungssubstanzen für Antikörper und deren Verwendung für Immunoassays oder Vakzine
AUPM411994A0 (en) * 1994-02-25 1994-03-24 Deakin Research Limited Epitopes
US5948763A (en) * 1995-06-07 1999-09-07 New York University Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
EP1186662A3 (en) * 1996-05-29 2003-01-15 McGILL UNIVERSITY Prion binding proteins and uses thereof
GB2319607A (en) * 1996-11-23 1998-05-27 Electrophoretics International Detection of prion proteins in mononuclear cells
US20020168689A1 (en) * 1997-02-06 2002-11-14 O'connor Michael Immunological assay for Spongiform Encephalopathies
AU738606B2 (en) * 1997-02-06 2001-09-20 Enfer Technology Limited Immunological assay for spongiform encephalopathies
JP2001512311A (ja) 1997-02-14 2001-08-21 ドイチェス クレブスフォルシュンクスツェントルム スチフトゥング デス エッフェントリヒェン レヒツ 優性ネガティブプリオンタンパク質変異体によるプリオン伝達阻害
EP0861900A1 (en) * 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions
US6127338A (en) * 1997-04-01 2000-10-03 Calyx Therapeutics, Inc. Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes
JP2002501385A (ja) * 1997-05-30 2002-01-15 ヴァイス ステファン 可溶性ラミニン受容体前駆体及びその相互作用を阻止するための方法
DE19725619A1 (de) * 1997-06-17 1998-12-24 Fraunhofer Ges Forschung Peptide als Agonisten und/oder Inhibitoren der Amyloidbildung und Zytotoxizität sowie der Verwendung bei Alzheimer'schen Krankheit, beim Typ II Diabetes mellitus und bei spongiformen Encephalopathien
DE19741607A1 (de) * 1997-09-20 1999-03-25 Prionics Ag Synthetische Polypeptide zur Diagnose und Therapie von Prionerkrankungen
US6211149B1 (en) 1998-08-03 2001-04-03 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors of formation of protease resistant prion protein
US6166187A (en) * 1999-03-05 2000-12-26 The Regents Of The University Of California Method of concentrating prion proteins in blood samples
AU5602100A (en) 1999-06-09 2000-12-28 Arch Development Corporation Recombinant prion-like genes and proteins and materials and methods comprising same
US7041807B1 (en) 1999-06-23 2006-05-09 Caprion Pharmaceuticals, Inc. Antibodies to a YYX epitope of a mammalian prion protein
EP1194164B8 (en) * 1999-06-23 2007-03-21 IDEXX Laboratories Inc Prion protein peptides and uses thereof
US6872806B1 (en) * 1999-06-25 2005-03-29 The Governors Of The University Of Alberta Polypeptide compositions formed using a coiled-coil template and methods of use
US6261790B1 (en) 1999-07-15 2001-07-17 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies
US6437102B1 (en) 1999-11-24 2002-08-20 Bayer Corporation Method of separating prions from biological materials
CA2405568A1 (en) * 2000-04-05 2001-10-18 North Carolina State University Prion-binding peptidic ligands and methods of using same
EP1158003B2 (en) * 2000-05-23 2012-12-26 Blood Transfusion Centre of Slovenia Antibodies capable to selectively detect prion PrP Sc isoforms
US7098317B1 (en) 2000-05-23 2006-08-29 Blood Transfusion Center Of Slovenia Antibodies capable to selectively detect prion PrPSc isoforms
IL148202A0 (en) * 2000-06-20 2002-09-12 Caprion Pharmaceuticals Inc Copolymers and methods of treating prion-related diseases
NZ515982A (en) * 2000-12-08 2003-09-26 Fujirebio Kk Method and monoclonal antibodies for differentiation between abnormal and normal prions
IES20010042A2 (en) * 2001-01-19 2002-12-11 Enfer Technology Ltd Test for transmissible spongiform encephalopathies
US6613505B2 (en) 2001-04-12 2003-09-02 Bioresource International, Inc. Composition and method for destruction of infetious prion proteins
EP1395833B1 (en) * 2001-05-31 2013-02-27 Adlyfe, Inc. Misfolded protein sensor method
US20050026165A1 (en) * 2001-05-31 2005-02-03 Cindy Orser Detection of conformationally altered proteins and prions
NZ536054A (en) * 2002-04-09 2009-10-30 Scripps Research Inst Motif-grafted hybrid polypeptides and uses thereof
DE10230141B4 (de) * 2002-07-04 2004-07-15 Priontype Gmbh Verfahren und Kit zur Anreicherung und zum Nachweis von veränderten Prion-Proteinen (PrPSc)
EP1534746A2 (en) * 2002-08-23 2005-06-01 Copenhagen Biotech Assets APS Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins
US20040072236A1 (en) * 2002-09-27 2004-04-15 Neil Cashman PrPSc -interacting molecules and uses thereof
DK1573323T3 (da) * 2002-12-03 2012-01-23 Pathogen Removal & Diagnostic Technologies Inc Prion-proteinligander samt fremgangsmåder til anvendelse deraf
US6979672B2 (en) * 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
EP1449536A1 (en) * 2003-02-14 2004-08-25 Prionics AG Prion proteins (PrP) as therapeutic agents for the treatment of AP-1 associated diseases
US20040192887A1 (en) * 2003-03-25 2004-09-30 Ralph Zahn PH-dependent polypeptide aggregation and its use
US7510848B2 (en) * 2003-04-04 2009-03-31 North Carolina State University Prion protein binding materials and methods of use
WO2004090102A2 (en) 2003-04-04 2004-10-21 American Red Cross Prion protein binding materials and methods of use
DK1653844T3 (da) 2003-08-13 2013-03-11 Novartis Vaccines & Diagnostic Prionspecifikke peptidreagenser
US20060035242A1 (en) * 2004-08-13 2006-02-16 Michelitsch Melissa D Prion-specific peptide reagents
RU2267496C2 (ru) * 2004-01-15 2006-01-10 Сергей Иванович Черныш Противоопухолевые и антивирусные пептиды
FR2865280B1 (fr) * 2004-01-20 2007-01-12 Biomerieux Sa Procede de detection de la prp utilisant une molecule ayant au moins une charge positive et/ou au moins une liaison osidique et un ligand autre qu'un ligand proteique
GB0402123D0 (en) * 2004-01-30 2004-03-03 Protherics Plc Method
GB0416699D0 (en) 2004-07-27 2004-09-01 Prometic Biosciences Ltd Prion protein ligands and methods of use
US20060057671A1 (en) * 2004-09-10 2006-03-16 Orser Cindy S Immobilized probes and methods of detecting conformationally altered prion proteins
WO2006076683A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Isolation and detection of pathogenic prions
MX2007008497A (es) * 2005-01-13 2007-09-14 Novartis Vaccines & Diagnostic Ensayos inmunosorbentes enlazados a enzimas usando reactivos de peptidos especificos de prion.
EP1853915B1 (en) * 2005-02-15 2011-10-12 Adlyfe, Inc. Method for detecting misfolded proteins and prions
WO2006131768A2 (en) 2005-06-10 2006-12-14 Prometic Biosciences Limited Triazines as protein binding ligands
KR20080048527A (ko) 2005-09-09 2008-06-02 노파르티스 아게 프리온-특이적 펩토이드 시약
US20070196863A1 (en) * 2006-02-17 2007-08-23 Hanson Technologies, Inc. Prion protein detection
WO2008013859A2 (en) * 2006-07-28 2008-01-31 Adlyfe, Inc. Peptide probes for diagnostics and therapeutics
CA2721982A1 (en) * 2008-04-30 2009-11-05 Novartis Ag Assay for pathogenic conformers
EP2135880A1 (en) 2008-06-17 2009-12-23 Heinrich-Heine-Universität Düsseldorf Anti-prion protein antibody fragment
AU2009301580B2 (en) 2008-10-06 2015-11-26 The University Of British Columbia Methods and systems for predicting misfolded protein epitopes
US9492472B2 (en) * 2008-12-23 2016-11-15 Case Western Reserve University Compositions and methods of treating cancer
AU2010220781A1 (en) * 2009-03-02 2011-10-06 The University Of British Columbia Antibodies and epitopes specific to misfolded prion protein
US20150147346A1 (en) * 2012-05-02 2015-05-28 Samuel Bogoch Replikin sequences and their antibodies for diagnostics, therapeutics, and vaccines against prion and neurodegenerative disorders including alzheimer's disease
MY204234A (en) 2018-08-27 2024-08-16 Regeneron Pharma Use of raman spectroscopy in downstream purification

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023432A1 (en) * 1992-05-15 1993-11-25 New York University Soluble prion polypeptides, and methods for detecting and purifying thereof

Also Published As

Publication number Publication date
US7777011B2 (en) 2010-08-17
CA2124953A1 (en) 1993-06-10
DE69228701D1 (de) 1999-04-22
AU3089292A (en) 1993-06-28
JPH07501798A (ja) 1995-02-23
CA2124953C (en) 2008-02-05
US20030199013A1 (en) 2003-10-23
GR3029740T3 (en) 1999-06-30
ATE177754T1 (de) 1999-04-15
DE69228701T2 (de) 1999-07-29
US6379905B1 (en) 2002-04-30
WO1993011155A1 (en) 1993-06-10
US5773572A (en) 1998-06-30
EP0616613A1 (en) 1994-09-28
EP0616613B1 (en) 1999-03-17
NZ246059A (en) 1995-08-28
AU675053B2 (en) 1997-01-23
JP4233604B2 (ja) 2009-03-04
ES2128362T3 (es) 1999-05-16

Similar Documents

Publication Publication Date Title
DK0616613T3 (da) Fragmenter af prionprotein
DE68924928D1 (de) Antikörper gegen latente Proteine von menschlichen Papillomavirus, diagnostische Systeme und Methoden.
FI914908A0 (fi) Ny monoklonal antikropp med ny antigen relaterad till humana tumoerer.
DK0650512T3 (da) Aldehyd-hærdet klæbemiddel på grundlag af protein
ATE255906T1 (de) Antikörper gegen cd40
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
ATE160575T1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
DE69111930D1 (de) Künstlicher Antikörper.
ATE171473T1 (de) Humanisierte monoklonale antikörper gegen humanes interleukin - 4
SE8403630D0 (sv) Humana proteiner
PT840620E (pt) Antagonistas de il-8 para o tratamento de asma
ES2157979T3 (es) Titulacion inmunologica competitiva por medio de una proteina de union utilizada en una estructura de anticuerpos multiclonal.
DE69010942D1 (de) Zusammengesetzte asphärische Linse.
ES2072423T3 (es) Anticuerpo monoclonal e inmunoensayo para el factor beta xiia de coagulacion de la sangre.
ES2168253T3 (es) Peptidos especificos para hcmv y su utilizacion.
FI902735A0 (fi) Monoklonal antikropp reaktiv foer en visst vidstraeckt i olika maenskoleukemi- och lymfomaceller foerekommande antigen och metoder foer dess anvaendning i diagnos och vaord.
FI934963A7 (fi) CTAA 81AV78, monoklonaalisen 81AV78-humaanivasta-aineen tunnistama ant igeeni
ES2103017T3 (es) Sueros estandares y de control para empleo en ensayos para anticuerpos.
NO890116L (no) Monoklonale antistoffer.
ATE184286T1 (de) Hgpiib-fragmente und ihre verwendung in in-vitro- verfahren zur bestimmung von in vivo stattfindenden thrombotischen ereignissen
DE69023717D1 (de) Monoklonaler Antikörper.
DE68912772D1 (de) Monoklonaler antikörper gegen entero-viren.
DE69020315D1 (de) Monoklonaler antikörper gegen c-reaktives protein.
EA199800028A1 (ru) Винилсульфоксиды и способы их синтеза
ES2196360T3 (es) Ensayo de western blot que sirve para la identificacion de anticuerpos especificos del virus cmvh.